| scholarly article | Q13442814 |
| P2093 | author name string | Yanli Wang | |
| Liang Bai | |||
| Jianglin Fan | |||
| Enqi Liu | |||
| Sihai Zhao | |||
| P2860 | cites work | Uromodulin promoter directs high-level expression of biologically active human alpha1-antitrypsin into mouse urine | Q24534183 |
| Recombinant human butyrylcholinesterase from milk of transgenic animals to protect against organophosphate poisoning | Q24683895 | ||
| An interspecific Nicotiana hybrid as a useful and cost-effective platform for production of animal vaccines | Q28730453 | ||
| Characterization of an avian influenza A (H5N1) virus isolated from a child with a fatal respiratory illness | Q29615389 | ||
| Plant-made vaccines for humans and animals. | Q30386732 | ||
| N- and O-glycans of recombinant human C1 inhibitor expressed in the milk of transgenic rabbits | Q31003775 | ||
| N-glycans of recombinant human acid alpha-glucosidase expressed in the milk of transgenic rabbits | Q33273194 | ||
| Biopharmaceutical production in transgenic livestock | Q33719380 | ||
| Transgenic plants as factories for biopharmaceuticals | Q34076132 | ||
| Recombinant protein expression in milk of livestock species | Q34097145 | ||
| Transgenic animal bioreactors | Q34114603 | ||
| Production of transgenic rabbits, sheep and pigs by microinjection | Q34193902 | ||
| Advances in Escherichia coli production of therapeutic proteins | Q34208144 | ||
| Enzyme therapy for pompe disease with recombinant human alpha-glucosidase from rabbit milk | Q34281037 | ||
| Understanding the art of producing protein and nonprotein molecules in Escherichia coli | Q34447830 | ||
| Production of pharmaceutical proteins by transgenic animals | Q34744705 | ||
| [Expression of human interferon beta in the mammary gland of transgenic rabbits] | Q81391615 | ||
| Production of recombinant human protein C in the milk of transgenic rabbits from the F3 generation | Q82848177 | ||
| Production of transgenic mice and rabbits that carry and express the human tissue plasminogen activator cDNA under the control of a bovine alpha S1 casein promoter | Q83850938 | ||
| Selecting an appropriate method for expressing a recombinant protein | Q35011411 | ||
| Making recombinant proteins in animals--different systems, different applications. | Q35209242 | ||
| Transgenic rabbits as therapeutic protein bioreactors and human disease models | Q35209836 | ||
| The transgenic rabbit as model for human diseases and as a source of biologically active recombinant proteins. | Q35577270 | ||
| Application of transgenesis in livestock for agriculture and biomedicine | Q35595366 | ||
| Oviduct-specific expression of two therapeutic proteins in transgenic hens. | Q35612590 | ||
| Application of inducible and targeted gene strategies to produce transgenic fish: a review | Q35746182 | ||
| Foundation Review: Transgenic animals and their impact on the drug discovery industry. | Q36143388 | ||
| Expression of human growth hormone in the milk of transgenic rabbits with transgene mapped to the telomere region of chromosome 7q. | Q36336482 | ||
| European community and US-FDA approval of recombinant human antithrombin produced in genetically altered goats | Q37619960 | ||
| Production of antibodies in plants: status after twenty years | Q37687534 | ||
| Adenoviral vector mediates high expression levels of human lactoferrin in the milk of rabbits | Q40018181 | ||
| Return to the Past: The Case for Antibody-Based Therapies in Infectious Diseases | Q40424596 | ||
| Expression and characterization of functional recombinant bovine follicle-stimulating hormone (boFSHalpha/beta) produced in the milk of transgenic rabbits | Q40703232 | ||
| Expression of recombinant human granulocyte macrophage-colony stimulating factor (hGM-CSF) in mouse urine | Q40794976 | ||
| Expression of a single betaalpha chain protein of equine LH/CG in milk of transgenic rabbits and its biological activity. | Q40812369 | ||
| The deleterious effects of human erythropoietin gene driven by the rabbit whey acidic protein gene promoter in transgenic rabbits | Q41243941 | ||
| Biosynthesis and cocoon-export of a recombinant globular protein in transgenic silkworms | Q42039615 | ||
| New and highly efficient method for silkworm transgenesis using Autographa californica nucleopolyhedrovirus and piggyBac transposable elements. | Q42043190 | ||
| Germline transformation of the silkworm Bombyx mori L. using a piggyBac transposon-derived vector. | Q42057359 | ||
| Characterization of a prion protein (PrP) gene from rabbit; a species with apparent resistance to infection by prions | Q42649627 | ||
| Production of recombinant human erythropoietin/Fc fusion protein by genetically manipulated chickens | Q43298959 | ||
| Genes encoding a mouse monoclonal antibody are expressed in transgenic mice, rabbits and pigs | Q44239969 | ||
| Transgenic rabbit producing human growth hormone in milk. | Q44458042 | ||
| High level expression of recombinant human antithrombin in the mammary gland of rabbits by adenoviral vectors infection | Q44794707 | ||
| Generation and phenotypic analysis of a transgenic line of rabbits secreting active recombinant human erythropoietin in the milk. | Q45179408 | ||
| Transgenic pigs produce functional human factor VIII in milk | Q45883787 | ||
| Production and processing of milk from transgenic goats expressing human lysozyme in the mammary gland | Q46523142 | ||
| Production of biologically active salmon calcitonin in the milk of transgenic rabbits | Q47857073 | ||
| Transgenically produced human antithrombin: structural and functional comparison to human plasma-derived antithrombin. | Q48004775 | ||
| First US approval for a transgenic animal drug | Q48035259 | ||
| Expression of recombinant human factor VIII in milk of several generations of transgenic rabbits | Q48292669 | ||
| Expression of active recombinant human lactoferrin in the milk of transgenic goats. | Q51725485 | ||
| Recombinant human alpha-glucosidase from rabbit milk in Pompe patients. | Q55034196 | ||
| Human nerve growth factor beta (hNGF-β): mammary gland specific expression and production in transgenic rabbits | Q57174238 | ||
| Stable production of human insulin-like growth factor 1 (IGF-1) in the milk of hemi- and homozygous transgenic rabbits over several generations | Q57174257 | ||
| Human Insulin-Like Growth Factor I (IGF-I) Produced in the Mammary Glands of Transgenic Rabbits: Yield, Receptor Binding, Mitogenic Activity, and Effects on IGF-Binding Proteins | Q57198132 | ||
| Expression of synthetic cDNA sequences encoding human insulin-like growth factor-1 (IGF-1) in the mammary gland of transgenic rabbits | Q57198143 | ||
| Expression of active recombinant human $alpha;1-antitrypsin in transgenic rabbits | Q57713278 | ||
| High-level expression of recombinant human nerve growth factor beta in milk of nontransgenic rabbits | Q64376643 | ||
| Rabbit beta-casein promoter directs secretion of human interleukin-2 into the milk of transgenic rabbits | Q67527238 | ||
| Production of functional human hemoglobin in transgenic swine | Q67528856 | ||
| Human parathyroid hormone as a secretory peptide in milk of transgenic mice | Q71750655 | ||
| An isologous porcine promoter permits high level expression of human hemoglobin in transgenic swine | Q72272050 | ||
| Transgenic rabbits as bioreactors for the production of human growth hormone | Q72343239 | ||
| Expression of human lactoferrin in milk of transgenic mice | Q72456336 | ||
| Expression of active human blood clotting factor VIII in mammary gland of transgenic rabbits | Q73011515 | ||
| Human acid alpha-glucosidase from rabbit milk has therapeutic effect in mice with glycogen storage disease type II | Q73142656 | ||
| Seminal vesicle production and secretion of growth hormone into seminal fluid | Q73143430 | ||
| Expression of bovine beta-lactoglobulin/human erythropoietin fusion protein in the milk of transgenic mice and rabbits | Q73341007 | ||
| Recombinant human extracellular superoxide dismutase produced in milk of transgenic rabbits | Q73532490 | ||
| Validating the hen as a bioreactor for the production of exogenous proteins in egg white | Q73553798 | ||
| Expression of active human erythropoietin in the mammary gland of lactating transgenic mice and rabbits | Q73574275 | ||
| The bladder as a bioreactor: urothelium production and secretion of growth hormone into urine | Q74109358 | ||
| Expression of human erythropoietin transgenes and of the endogenous WAP gene in the mammary gland of transgenic rabbits during gestation and lactation | Q77704829 | ||
| Expression of exogenous protein in the egg white of transgenic chickens | Q77847907 | ||
| High level expression of tissue-nonspecific alkaline phosphatase in the milk of transgenic rabbits | Q79853983 | ||
| Biomanufacturing, from bust to boom...to bubble? | Q80969442 | ||
| Purification and characterization of a recombinant version of human alpha-fetoprotein expressed in the milk of transgenic goats | Q81038309 | ||
| P275 | copyright license | Creative Commons Attribution 3.0 Unported | Q14947546 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | bioreactor | Q864699 |
| P304 | page(s) | 580463 | |
| P577 | publication date | 2013-03-17 | |
| P1433 | published in | BioMed Research International | Q17509958 |
| P1476 | title | Expression systems and species used for transgenic animal bioreactors | |
| P478 | volume | 2013 |
| Q56557417 | A novel recombinant human plasminogen activator: Efficient expression and hereditary stability in transgenic goats and in vitro thrombolytic bioactivity in the milk of transgenic goats |
| Q92732253 | Accurately cleavable goat β-lactoglobulin signal peptide efficiently guided translation of a recombinant human plasminogen activator in transgenic rabbit mammary gland |
| Q36158788 | Adeno-associated-virus-mediated transduction of the mammary gland enables sustained production of recombinant proteins in milk |
| Q57285329 | Avian Bioreactor Systems: A Review |
| Q26768505 | Cellular reprogramming in farm animals: an overview of iPSC generation in the mammalian farm animal species |
| Q37138255 | Characterization of anti-CD20 monoclonal antibody produced by transgenic silkworms (Bombyx mori). |
| Q55020686 | Delipidation of Plasma Has Minimal Effects on Human Butyrylcholinesterase. |
| Q52934589 | Generation of induced pluripotent stem cells from domestic goats. |
| Q34431649 | Genome editing of BmFib-H gene provides an empty Bombyx mori silk gland for a highly efficient bioreactor. |
| Q37039471 | Improved development of somatic cell cloned bovine embryos by a mammary gland epithelia cells in vitro model |
| Q38701179 | New Mammalian Expression Systems |
| Q39025466 | Non-conventional expression systems for the production of vaccine proteins and immunotherapeutic molecules |
| Q35897441 | Oral Administration of Silkworm-Produced GAD65 and Insulin Bi-Autoantigens against Type 1 Diabetes |
| Q58569006 | Production of Recombinant Proteins in the Milk of Transgenic Animals: Current State and Prospects |
| Q56569049 | Production of functional human CuZn-SOD and EC-SOD in bitransgenic cloned goat milk |
| Q37602144 | Production of functional human nerve growth factor from the saliva of transgenic mice by using salivary glands as bioreactors. |
| Q26853133 | Rabbit models for the study of human atherosclerosis: from pathophysiological mechanisms to translational medicine |
| Q92542772 | Recent Developments in Bioprocessing of Recombinant Proteins: Expression Hosts and Process Development |
| Q33780365 | Recombinant human plasma phospholipid transfer protein (PLTP) to prevent bacterial growth and to treat sepsis. |
| Q38714835 | The transgenic animal platform for biopharmaceutical production |
Search more.